TREACE MEDICAL CONCEPTS, INC. (TMCI) — SEC Filings

Latest SEC filings for TREACE MEDICAL CONCEPTS, INC. (TMCI), explained in plain English.

Sentiment Overview: 2 bullish, 24 neutral, 2 mixed

Recent Filings (28)

• Treace Medical Concepts Files 2025 Annual Report — ARS · 2026-04-06T08:49:47-04:00 [neutral] Risk: low
  Treace Medical Concepts, Inc. filed its Annual Report to Security Holders (ARS) on April 6, 2026, for the period ending December 31, 2025. The company, headquar
• Treace Medical Concepts Files Definitive Proxy Statement — DEFA14A · 2026-04-06T08:49:11-04:00 [neutral] Risk: low
  Treace Medical Concepts, Inc. filed a Definitive Proxy Statement (DEFA14A) on April 6, 2026. This filing is related to the solicitation of proxies from sharehol
• Treace Medical Concepts Enters New Agreements, Terminates Others — 8-K · 2025-12-18T00:00:00.000Z [neutral] Risk: medium
  On December 16, 2025, Treace Medical Concepts, Inc. entered into a material definitive agreement and terminated another. The company also created a direct finan
• Treace Medical Concepts Sees Revenue Growth Amidst Widening Quarterly Loss — 10-Q · 2025-11-06T00:00:00.000Z [mixed] Risk: high
  Treace Medical Concepts, Inc. (TMCI) reported revenue of $50.214 million for the three months ended September 30, 2025, an 11.4% increase from $45.086 million i
• Treace Medical Revenue Jumps 16.5%, But Net Loss Widens — 10-Q · 2025-08-07T00:00:00.000Z [mixed] Risk: medium
  Treace Medical Concepts, Inc. reported net revenue of $49.6 million for the three months ended June 30, 2025, a 15.6% increase from $42.9 million in the prior-y
• Treace Medical Concepts Files 8-K — 8-K · 2025-05-21T00:00:00.000Z [neutral] Risk: low
  On May 21, 2025, Treace Medical Concepts, Inc. filed an 8-K report. The filing primarily concerns the submission of matters to a vote of security holders and in
• Treace Medical Concepts Q1 2025 10-Q Filed — 10-Q · 2025-05-08T00:00:00.000Z [neutral] Risk: medium
  Treace Medical Concepts, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information, including assets, liabilities, and
• Treace Medical Concepts Files 8-K on Officer/Director Changes — 8-K · 2025-04-07T00:00:00.000Z [neutral] Risk: medium
  Treace Medical Concepts, Inc. filed an 8-K on April 7, 2025, reporting on the departure of directors or certain officers, the election of directors, the appoint
• 10-K Filing — 10-K · 2025-02-27T00:00:00.000Z [neutral]
• 8-K Filing — 8-K · 2025-01-13T00:00:00.000Z [neutral]
• SC 13G Filing — SC 13G · 2024-11-14T00:00:00.000Z [neutral]
• SC 13G/A Filing — SC 13G/A · 2024-11-12T00:00:00.000Z [neutral]
• SC 13G Filing — SC 13G · 2024-11-08T00:00:00.000Z [neutral]
• SC 13G/A Filing — SC 13G/A · 2024-11-07T00:00:00.000Z [neutral]
• Treace Medical Concepts Files Q3 2024 10-Q — 10-Q · 2024-11-05T00:00:00.000Z [neutral] Risk: medium
  Treace Medical Concepts, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the
• SC 13G/A Filing — SC 13G/A · 2024-11-04T00:00:00.000Z [neutral]
• Treace Medical Concepts Files 8-K — 8-K · 2024-10-15T00:00:00.000Z [neutral] Risk: low
  On October 14, 2024, Treace Medical Concepts, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the submission of Financial S
• Treace Medical Concepts Files 10-Q — 10-Q · 2024-08-06T00:00:00.000Z [neutral] Risk: medium
  Treace Medical Concepts, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported on its financial position, including details on its revol
• Treace Medical Concepts Holds Shareholder Vote — 8-K · 2024-05-22T00:00:00.000Z [neutral] Risk: low
  On May 21, 2024, Treace Medical Concepts, Inc. filed an 8-K report detailing a shareholder meeting where proposals were submitted for a vote. The company, incor
• Treace Medical Concepts, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · 2024-05-07T00:00:00.000Z [neutral] Risk: medium
  TREACE MEDICAL CONCEPTS, INC. (TMCI) filed a Quarterly Report (10-Q) with the SEC on May 7, 2024. Filed a 10-Q report for the period ending March 31, 2024. The
• Treace Medical Concepts Schedules 2024 Annual Meeting of Stockholders — DEF 14A · 2024-04-02T00:00:00.000Z [neutral] Risk:
  TREACE MEDICAL CONCEPTS, INC. (TMCI) filed a Proxy Statement (DEF 14A) with the SEC on April 2, 2024. The 2024 Annual Meeting of Stockholders for Treace Medical
• Treace Medical Concepts, Inc. Files 2023 Annual Report (10-K) — 10-K · 2024-02-27T00:00:00.000Z [neutral] Risk: medium
  TREACE MEDICAL CONCEPTS, INC. (TMCI) filed a Annual Report (10-K) with the SEC on February 27, 2024. Filed 10-K for the fiscal year ending December 31, 2023. Co
• SC 13G/A Filing — SC 13G/A · 2024-02-14T00:00:00.000Z [neutral]
• SC 13G/A Filing — SC 13G/A · 2024-02-13T00:00:00.000Z [neutral]
• John T. Treace Holds 10.9M Shares in Treace Medical Concepts — SC 13G/A · 2024-02-09T00:00:00.000Z [bullish] Risk: low
  John T. Treace, a key figure at Treace Medical Concepts, Inc., filed an amended SC 13G/A on February 9, 2024, revealing a significant beneficial ownership of 10
• BlackRock Discloses Significant Passive Stake in Treace Medical Concepts — SC 13G · 2024-01-29T00:00:00.000Z [bullish]
  BlackRock Inc., a major investment firm, reported on January 29, 2024, that as of December 31, 2023, it holds a significant stake in Treace Medical Concepts, In
• TREACE MEDICAL CONCEPTS Confirms Nasdaq Listing & Public Status — 8-K · 2024-01-10T00:00:00.000Z [neutral]
  TREACE MEDICAL CONCEPTS, Inc. filed an 8-K on January 9, 2024, to disclose that it is a publicly traded company with its Common Stock, $0.001 par value per shar
• TREACE MEDICAL CONCEPTS Files 8-K on Operations & Financials — 8-K · 2024-01-08T00:00:00.000Z [neutral]
  TREACE MEDICAL CONCEPTS, Inc. filed an 8-K on January 8, 2024, to report on its results of operations and financial condition. This filing indicates that the co